← News
Commodities· May 05, 2026 at 05:17 PM
Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
Merck (NYSE:MRK) delivered its fourth consecutive earnings beat, but shares slipped on the earnings report. With acquisition charges clouding the quarter, here is where the stock heads next. The 24/7 Wall St. Price Target for Merck Is $135.70 Our 24/7 Wall St. price target for Merck is $135.70 over the next 12 months, implying 24.29% ... Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds
Affected symbols
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
GeopoliticsMedium impactNeutral1h
AMD, Intel and Micron Lead Chip Stocks Rally on U.S--Iran Ceasefire Optimism
via Yahoo Finance
NVDA
IndicesMedium impactNeutral1h
A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers
via Yahoo Finance
NVDA
StocksMedium impactNeutral1h
The chip trade is no longer just about Nvidia
via Yahoo Finance
NVDA
StocksMedium impactNeutral1h
Why Nvidia Stock Popped 14% in April and Could Go Even Higher
via Yahoo Finance
NVDA